The efficacy of Nicardipine versus Clevidipine in treating neurocritical care patients is an ongoing debate which strongly divides opinion; and so in this week's episode, Dr Alex Reynolds is joined by Colleen Bond, PharmD, and Andy Webb, PharmD, who from a pharmacy standpoint help us to navigate the debate and further our understanding of the pros and cons of each agent.